Background: Intravascular imaging with intravascular ultrasound (IVUS) and optical coherence
coronary artery dissection. IVUS can also determine vessel diameter, percent plaque burden, and minimal luminal area of intermediate coronary lesions, facilitate optimal stent sizing, and confirm stent apposition after percutaneous coronary intervention (PCI) [3] . Optical coherence tomography (OCT), an imaging modality that uses near-infrared light to generate high-resolution axial images of the coronary arteries, may also be used to complement angiography for similar indications [4, 5] Although there are many procedural advantages to coronary angiography with intravascular coronary imaging with IVUS or OCT, large observational studies and randomized controlled trials of intravascular imaging have not consistently demonstrated a clinical benefit in patients undergoing PCI [6] [7] [8] [9] [10] [11] .
Despite the wide availability of intravascular coronary imaging in cardiac catheterization laboratories nationwide, patterns of intravascular imaging use in contemporary clinical practice are not well characterized [12, 13] . In the present study, we examined trends in the use of intravascular imaging in United States hospitals over the span of a decade, and the outcomes of patients undergoing invasive coronary angiography with and without intravascular coronary imaging. and/or PCI with or without stent placement (CCS procedure code 45) during hospital admission, excluding hospitalizations with codes for right heart catheterization without coronary angiography. IVUS use was identified by ICD-9 procedure code 00.24 and OCT use was identified by ICD-9 procedure code 38.24. Acute myocardial infarction was identified using ICD-9 diagnosis codes for STEMI (410.01 to 410.61, 410.81, and 410.91) and non-ST-segment elevation myocardial infarction EMI (NSTEMI) (410.71). Bare metal and drug eluting stent placement were identified by ICD-9 procedure codes 36.06 and 36.07, respectively. Demographic, clinical, and hospital characteristics were recorded for all patients. The primary outcome was in-hospital all-cause mortality.
| M E TH ODS

| Study population
| Statistical analysis
Continuous variables are presented as mean 6 standard deviation (SD) and compared using the Independent-samples t test for univariate analyses. Categorical variables are presented as percentages and were compared by Chi-Squared tests. Multivariable logistic regression was used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CI) for the use of intravascular imaging and in-hospital outcomes.
Adjusted in-hospital mortality was determined from multivariable models with age as a continuous variable, sex, race, tobacco use, obesity, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease, CAD, congestive heart failure, anemia, malignancy, elective hospitalization, acute myocardial infarction, STEMI, primary expected payer, bed size, location, and geographic region as covariates. Unadjusted testing of trends over time were performed using the Cochran-Armitage test.
In order to determine variability in the use of intravascular imaging by hospital in contemporary practice, data were analyzed for hospitals with 75 PCI recorded in 2014. This time frame corresponds to a period in which 20% of discharges from all participating hospitals were included in the NIS.
Sampling weights were applied for trend analyses and to determine national incidence estimates, as per HCUP guidance. Unless otherwise specified, unweighted data were used in all analyses. Statistical analyses were performed using SPSS 20 (IBM SPSS Statistics, Armonk, NY) and R (R Foundation for Statistical Computing, Vienna, Austria).
Statistical tests are two-sided and P-values <0.05 were considered to be statistically significant. Table   1 ). Patients undergoing intravascular imaging were more likely to undergo PCI (81.0% vs. 45.2%, P < 0.001) and less likely to be referred for coronary artery bypass grafting (6.6% vs. 9.3%, P < 0.001) than those in whom intravascular imaging was not performed. The risks of intravascular coronary imaging are low, particularly among patients planned for PCI and for whom systemic anticoagulation, guide catheter, and guide wire placement are already required.
However, OCT does require the additional administration of a contrast bolus during image acquisition to eliminate blood swirl artifact, increasing risks of contrast-induced nephropathy. IVUS images can be obtained without use of any additional contrast material. Table 2 lists the key advantages and disadvantages of using intravascular imaging as an adjunct to coronary angiography.
In this retrospective analysis, intravascular imaging was associated with lower risk of in-hospital death among patients undergoing PCI or diagnostic angiography, with or without acute coronary syndromes.
This may be related to lower rates of stent malapposition or edge dissection associated with intravascular imaging during PCI. While hypothesis generating, these findings must be interpreted with caution, as the lower mortality observed in this study may be confounded by severity of presentation or by indication for PCI, and prior randomized trials have not consistently demonstrated a reduction in stent thrombosis associated with intravascular imaging [14, 15] . Alternatively, the use of intravascular imaging may reflect the presence of intermediate, rather than severe CAD and may simply identify a population with more favorable outcomes [16] .
Despite multiple randomized trials and registry studies comparing PCI with IVUS guidance versus conventional angiography alone, the a Adjusted for age, sex, race, tobacco use, obesity, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease, coronary artery disease, congestive heart failure, anemia, malignancy, elective hospitalization, acute myocardial infarction, STEMI, primary payer, hospital bed size, location, and geographic region. Abbreviations: NSTEMI: non-ST-segment elevation myocardial infarction, PCI: percutaneous coronary intervention, STEMI: ST-segment elevation myocardial infarction. Guide coronary stent placement Guide coronary intervention of ostial or left main lesions (IVUS only) Confirm optimal stent apposition/identify stent malapposition clinical benefit of IVUS imaging remains controversial [6] [7] [8] [9] [10] [11] . In the IVUS-XPL trial, 1,400 patients with long coronary lesions were randomized to receive IVUS-guided PCI versus angiography-guided PCI. IVUS was associated with lower rates of major adverse cardiovascular events at 1 year, driven largely by reduced ischemia-driven target lesion revascularization [9] . No differences in cardiac death and myocardial infarction at 1 year were observed. Similar reductions in target lesion and target vessel revascularization associated with IVUS-guided PCI have been reported in meta-analyses of randomized trials [15] . Data from large observational studies are mixed, with some studies supporting a benefit of IVUS-guided PCI [6] , while others report no improvement in patient outcomes [7] . 
| Study limitations
There are a number of limitations to this study. were analyzed as a simple random sample for the analyses without trends (i.e., without using weights). This may introduce empirical weighting and thus may not be reflective of the overall population.
Similarly, hospitals were not part of the NIS sampling frame in later years and are not representatively sampled. Finally, long-term outcomes after diagnostic angiography and PCI were not available from this in-hospital dataset.
| CON CL U S I ONS
In a large administrative inpatient database from the United States, overall utilization of intravascular imaging with invasive coronary angiography was low. Intravascular imaging was performed in only 2.8% of cases overall and only 4.8% of PCIs. There was substantial variation in the frequency of use of intravascular imaging during coronary procedures among US hospitals. Intravascular imaging was associated with reduced in-hospital mortality in patients undergoing diagnostic angiography and PCI. Additional investigation to determine the short-and long-term clinical benefits of IVUS and OCT using large-scale randomized controlled trials are warranted.
